Although the present investigation did not analyze cellular components, based on our findings, we hypothesize that the monocyte/macrophage activation during COVID-19 culminates in increased CXCL10 levels that ultimately contribute to the non-favorable clinical outcomes (MV and Death), signalizing the importance of scaling up chemokine-orchestrated immunity. This evidence concerns the gene CXCL10 and COVID-19.